Antiplatelet agents: their role in the prevention of sudden death.
D000818:Animals; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects; D002986:Clinical Trials as Topic; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D003645:Death, Sudden / Q000209:etiology*; D004176:Dipyridamole / Q000627:therapeutic use; D004285:Dogs; D004727:Endothelium / Q000378:metabolism; D006801:Humans; D008297:Male; D009130:Muscle, Smooth / Q000378:metabolism; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D010215:Papio; D010973:Platelet Adhesiveness / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis; D011817:Rabbits; D013442:Sulfinpyrazone / Q000009:adverse effects / Q000627:therapeutic use
D011453:Prostaglandins; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone